IBDEI0B0 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4945,1,2,0)
 ;;=2^J0713
 ;;^UTILITY(U,$J,358.3,4945,1,3,0)
 ;;=3^CEFTAZIDIME INJ PER 500 MG
 ;;^UTILITY(U,$J,358.3,4946,0)
 ;;=J0735^^26^315^10^^^^1
 ;;^UTILITY(U,$J,358.3,4946,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4946,1,2,0)
 ;;=2^J0735
 ;;^UTILITY(U,$J,358.3,4946,1,3,0)
 ;;=3^CLONIDINE HCL INJ PER 1 MG
 ;;^UTILITY(U,$J,358.3,4947,0)
 ;;=J1200^^26^315^15^^^^1
 ;;^UTILITY(U,$J,358.3,4947,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4947,1,2,0)
 ;;=2^J1200
 ;;^UTILITY(U,$J,358.3,4947,1,3,0)
 ;;=3^DIPHENHYDRAMINE HCL PER 50 MG
 ;;^UTILITY(U,$J,358.3,4948,0)
 ;;=J1270^^26^315^16^^^^1
 ;;^UTILITY(U,$J,358.3,4948,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4948,1,2,0)
 ;;=2^J1270
 ;;^UTILITY(U,$J,358.3,4948,1,3,0)
 ;;=3^DOXERCALCIFEROL INJ PER 1 MCG
 ;;^UTILITY(U,$J,358.3,4949,0)
 ;;=J1580^^26^315^20^^^^1
 ;;^UTILITY(U,$J,358.3,4949,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4949,1,2,0)
 ;;=2^J1580
 ;;^UTILITY(U,$J,358.3,4949,1,3,0)
 ;;=3^GARAMYCIN GENTAMICIN PER 80 MG
 ;;^UTILITY(U,$J,358.3,4950,0)
 ;;=J1642^^26^315^22^^^^1
 ;;^UTILITY(U,$J,358.3,4950,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4950,1,2,0)
 ;;=2^J1642
 ;;^UTILITY(U,$J,358.3,4950,1,3,0)
 ;;=3^HEPARIN SODIUM INJ PER 10 U (FLUSH)
 ;;^UTILITY(U,$J,358.3,4951,0)
 ;;=J1644^^26^315^23^^^^1
 ;;^UTILITY(U,$J,358.3,4951,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4951,1,2,0)
 ;;=2^J1644
 ;;^UTILITY(U,$J,358.3,4951,1,3,0)
 ;;=3^HEPARIN SODIUM INJ PER 1000 U
 ;;^UTILITY(U,$J,358.3,4952,0)
 ;;=J2060^^26^315^29^^^^1
 ;;^UTILITY(U,$J,358.3,4952,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4952,1,2,0)
 ;;=2^J2060
 ;;^UTILITY(U,$J,358.3,4952,1,3,0)
 ;;=3^LORAZEPAM INJ PER 2 MG
 ;;^UTILITY(U,$J,358.3,4953,0)
 ;;=J2405^^26^315^32^^^^1
 ;;^UTILITY(U,$J,358.3,4953,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4953,1,2,0)
 ;;=2^J2405
 ;;^UTILITY(U,$J,358.3,4953,1,3,0)
 ;;=3^ONDANSETRON HCL INJ PER 1 MG
 ;;^UTILITY(U,$J,358.3,4954,0)
 ;;=J2997^^26^315^3^^^^1
 ;;^UTILITY(U,$J,358.3,4954,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4954,1,2,0)
 ;;=2^J2997
 ;;^UTILITY(U,$J,358.3,4954,1,3,0)
 ;;=3^ALTEPLASE RECOMBINANT PER 1 MG
 ;;^UTILITY(U,$J,358.3,4955,0)
 ;;=J3260^^26^315^40^^^^1
 ;;^UTILITY(U,$J,358.3,4955,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4955,1,2,0)
 ;;=2^J3260
 ;;^UTILITY(U,$J,358.3,4955,1,3,0)
 ;;=3^TOBRAMYCIN SULFATE PER 80 MG
 ;;^UTILITY(U,$J,358.3,4956,0)
 ;;=J7682^^26^315^39^^^^1
 ;;^UTILITY(U,$J,358.3,4956,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4956,1,2,0)
 ;;=2^J7682
 ;;^UTILITY(U,$J,358.3,4956,1,3,0)
 ;;=3^TOBRAMYCIN NON-COM UNIT 300 MG
 ;;^UTILITY(U,$J,358.3,4957,0)
 ;;=P9047^^26^315^2^^^^1
 ;;^UTILITY(U,$J,358.3,4957,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4957,1,2,0)
 ;;=2^P9047
 ;;^UTILITY(U,$J,358.3,4957,1,3,0)
 ;;=3^ALBUMIN (HUMAN), 25%, 50ML
 ;;^UTILITY(U,$J,358.3,4958,0)
 ;;=J3370^^26^315^42^^^^1
 ;;^UTILITY(U,$J,358.3,4958,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4958,1,2,0)
 ;;=2^J3370
 ;;^UTILITY(U,$J,358.3,4958,1,3,0)
 ;;=3^VANCOMYCIN HCL 500 MG
 ;;^UTILITY(U,$J,358.3,4959,0)
 ;;=J0636^^26^315^5^^^^1
 ;;^UTILITY(U,$J,358.3,4959,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4959,1,2,0)
 ;;=2^J0636
 ;;^UTILITY(U,$J,358.3,4959,1,3,0)
 ;;=3^CALCITRIOL INJ PER 0.1 MCG
 ;;^UTILITY(U,$J,358.3,4960,0)
 ;;=J0882^^26^315^11^^^^1
 ;;^UTILITY(U,$J,358.3,4960,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4960,1,2,0)
 ;;=2^J0882
 ;;^UTILITY(U,$J,358.3,4960,1,3,0)
 ;;=3^DARBEPOETIN ALFA,ESRD USE 1MCG
 ;;^UTILITY(U,$J,358.3,4961,0)
 ;;=J3490^^26^315^28^^^^1
 ;;^UTILITY(U,$J,358.3,4961,1,0)
 ;;=^358.31IA^3^2
